From Memios
Practical writing and video on living strong and active into your 90s. No hype, no supplements to sell. Just what the evidence supports and what it looks like on an ordinary Tuesday.
579 items

Morphine reliably relieves moderate to severe cancer pain: across 62 trials pooled by Cochrane, 96% of individually reported participants reached no worse than mild pain.
2026-10-03 · 25 min read

For community-acquired pneumonia, meta-analyses of randomised trials put moxifloxacin on a level with beta-lactam-based standard therapy for cure and for death.
2026-10-03 · 27 min read

For the one thing it is approved to treat on the skin — impetigo — the evidence is good: a Cochrane review of 68 randomised trials found topical antibiotics cured impetigo about twice as often as placebo.
2026-10-03 · 22 min read

It lowers blood pressure about as well as other common classes, and that is the extent of what has been shown for it.
2026-10-03 · 22 min read

Well established. Nifedipine lowers blood pressure and relieves angina caused by coronary artery spasm.
2026-10-03 · 26 min read

In the trial that led to approval, EPIC-HR, unvaccinated adults at high risk who started the drug within three days of symptoms had a 0.77% rate of COVID-19 hospitalisation or death by day 28 versus 7.01% on placebo - an absolute difference of 6.32 percentage points.
2026-10-03 · 22 min read

Well established. For simple bladder infection in women the evidence is good.
2026-10-03 · 41 min read

The honest summary is that nitroglycerin is a reliable symptom reliever and a poor outcome drug.
2026-10-03 · 33 min read

For contraception the evidence is reasonably solid: a 2023 review of 54 studies found a median typical-use Pearl Index of 1.63 pregnancies per 100 woman-years for progestin-only pills.
2026-10-03 · 23 min read

Well established. Approved only for depression, nortriptyline is used far more widely than that.
2026-10-03 · 28 min read

Nystatin kills Candida on contact with the surfaces it touches, and its evidence is correspondingly local and uneven. A systematic review found nystatin pastilles clearly better than placebo for denture-associated candidiasis.
2026-10-03 · 27 min read

Ofloxacin clears common bacterial infections: in a 688-patient randomised trial in women with uncomplicated cystitis a 3-day course eradicated the organism in 97% and achieved clinical success in 96%.
2026-10-03 · 36 min read

It reduces the symptoms of psychosis and mania, and the randomised evidence for that is strong.
2026-10-03 · 27 min read

The approved use is narrow and the evidence for it is clean: in two small randomised trials.
2026-10-03 · 39 min read

The question of what oseltamivir actually achieves is one of the most publicly fought-over in modern drug evidence, because for years most of the trial data sat unpublished with the manufacturer.
2026-10-03 · 31 min read

Oxcarbazepine's active metabolite blocks voltage-sensitive sodium channels, which stops over-excitable nerve membranes firing repeatedly.
2026-10-03 · 42 min read

For an overactive bladder, systematic reviews of randomised trials find that antimuscarinics including oxybutynin produce real but small average improvements in leakage and urinary frequency compared with placebo.
2026-10-03 · 24 min read

For people whose pancreas cannot produce enough digestive enzymes, pancrelipase measurably restores fat and protein absorption. In cystic fibrosis trials.
2026-10-03 · 46 min read

Limited evidence. Phentermine produces modest short-term weight loss on top of diet.
2026-10-03 · 29 min read

Pioglitazone makes muscle, fat and liver tissue more responsive to the insulin a person already makes, which lowers blood glucose.
2026-10-03 · 27 min read

Well established. The evidence here is consistent in direction but weak in quality.
2026-10-03 · 29 min read

Limited evidence. The evidence base specific to this combination is thin and old.
2026-10-03 · 26 min read

For Parkinson's disease, trials show it improves motor symptoms and, started before levodopa, delays motor complications.
2026-10-03 · 35 min read

Prazosin relaxes small arteries by blocking alpha-1 receptors, lowering blood pressure by a modest amount: a Cochrane review of alpha blockers put the best estimate at -8/-5 mmHg and said even that is likely an overestimate.
2026-10-03 · 19 min read
0:00/0:00